Diclofenac injection 25 mg/ml 3 ml – [5 ampoules]

Diclofenac has anti-inflammatory, analgesic and antipyretic effects. Indiscriminately inhibiting cyclooxygenase 1 and 2, disrupts the metabolism of arachidonic acid, reduces the number of prostaglandins in the focus of inflammation. In rheumatic diseases anti-inflammatory and analgesic effect of diclofenac contributes to a significant reduction in the severity of pain, morning stiffness, joint swelling that improves the functional state of the joint. In trauma. in postoperative period diclofenac reduces pain and inflammatory swelling.

For the short-term treatment of pain of different genesis, of moderate intensity:

– musculoskeletal disorders (rheumatoid arthritis, psoriatic, juvenile chronic arthritis, ankylosing spondylitis; gouty arthritis, rheumatic soft tissue lesions, osteoarthritis of peripheral joints and spine (including with radicular syndrome);

– lumbago, sciatica, neuralgia;

– Algodysmenorrhea, pelvic inflammatory processes, including adnexitis;

– Post-traumatic pain syndrome, accompanied by inflammation;

– postoperative pain.

The drug is intended as symptomatic therapy, reduces pain and inflammation at the time of use, has no effect on the progression of the disease.

Hypersensitivity (including to other NSAIDs or auxiliary components). NSAIDs or auxiliary components), erosive-ulcerative lesions of the gastrointestinal tract (in the acute phase), bleeding from the gastrointestinal tract, inflammatory bowel disease, marked liver failure, liver disease in the acute period, severe renal insufficiency (creatinine clearance less than 30 ml/min), hyperkalemia, complete or incomplete acetylsalicylic acid intolerance syndrome (rhinosinusitis, urticaria, nasal polyps, bronchial asthma, arising from taking acetylsalicylic acid or other NSAIDs) hematopoiesis disorders, hemostasis disorders (including hemophilia), pregnancy, childhood (under 18 years), lactation, period after coronary artery bypass grafting, at high risk of arterial thrombosis and thromboembolism, chronic heart failure, coronary heart disease, peripheral artery disease and cerebrovascular disease.